NCT06468956
Efficacy and Safety Study of SHR-1819 Injection in Adult Patients With Severe Atopic Dermatitis
레지스트리 요약
- 진행 상태
- 완료 (COMPLETED)
- 질환/조건
- Moderate to Severe Atopic Dermatitis
- 시험 유형
- 중재 연구 (INTERVENTIONAL)
- 단계
- Phase 3
- 목적
- 치료
- 중재 유형
- 약물
- 개입·치료
- SHR-1819, Placebo
- Lead Sponsor
- Guangdong Hengrui Pharmaceutical Co., Ltd (산업계)
캐시 시각: 2026-09-04 00:16:45
요약
This trial was designed to evaluate the efficacy and safety of SHR-1819 injection in patients with atopic dermatitis.
카카오 로그인 후 의뢰